Long-term outcome of treatment for ann arbor Stage I Hodgkin's disease: Prognostic factors for survival and freedom from progression

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 3, 1997, Pages 593-599

  Vlachaki, Maria T ^a   Hagemeister, Frederick B ^a   Fuller, Lillian M ^a   Besa, Pelayo C ^a   Hess, Mark A ^a   Brown, Barry ^a   Cabanillas, Fernando ^a   Cox, James D ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UTMDACC   (United States)

Author keywords

Hodgkin's disease; Prognosis; Radiation technique

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME;

EID: 0030785808     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00036-9     Document Type: Article

References (30)

1. Carbone, P. P.; Kaplan, H. S.; Musshoff, K.; Smithers, D. W.; Tubiana, M. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 31:1860-1861; 1971.
2. Cosset, J. M.; Henry-Amar, M.; Meerwaldt, J. H.; Carde, P.; Noordijk, E. M.; Thomas, J.; Burgers, J. M. V.; Somers, R.; Hayat, M.; Tubiana, M. (on behalf of the EORTC Lymphoma Cooperative Group). The EORTC Trials for Limited Stage Hodgkin's Disease. Eur. J. Cancer 28A:1847-1850; 1992.
3. Cox, D. Regression models and life-tables (with discussion). J. Royal Statist. Soc. 34:187-220; 1972.
4. Cox, J. D. Lymphomas and leukemia. In Cox, J. D., ed. Moss' radiation oncology: Rationale, technique, results. St. Louis, MO: Mosby-Year Book; 1994:795-826.
5. Cox, J. D.; Stoffel, T. J. Clinical versus pathologic Stage I and II Hodgkin's disease. Oncology 37:325-328; 1980.
6. Crhkovich, M. J.; Leopold, K.; Hoppe, R. T.; Mauch, P. Stage I to IIB Hodgkin's disease: The combined experience at Stanford University and the Joint Center for Radiation Therapy. J. Clin. Oncol. 5:1041-1049; 1987.
7. Ganesan, T. S.; Wrigley, P. F. M.; Murray, P. A.; Stansfeld, A. G.; d'Ardenne, A. J.; Arnott, S.; Jones, A.; Shand, W. S.; Malpas, J. S. and Lister, T. A. Radiotherapy for Stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital. Br. J. Cancer 62:314-318; 1990.
8. Gospodarowicz, M. K.; Sutcliffe, S. B.; Bergsagel, D. E., et al. Radiation therapy in clinical Stage I and II Hodgkin's disease. Eur. J. Cancer 28A:1841-1846; 1992.
9. Hagemeister, F. B.; Fuller, L. M.; Martin, R. G. Staging laparotomy: Findings and applications to treatment decisions. In: Fuller, L. M.; Hagemeister, F. B.; Sullivan, M. P., et al., eds. Hodgkin's disease and non-Hodgkin's lymphomas in adults and children. New York: Raven Press; 1988:170-185.
10. Hagemeister, F. B.; Fuller, L. M.; Velasquez, W. S.; Sullivan, J. A.; North, L.; Butler, J. J.; Johnston, D. A.; Shullenberger, C. C. Involved field radiotherapy versus extended field radiotherapy versus involved field radiotherapy followed by six cycles of MOPP. Cancer Treat. Rep. 66:789-798; 1982.
11. Hellman, S.; Mauch, P. Role of radiation therapy in the treatment of Hodgkin's disease. Cancer Treat. Rep. 66:915-23; 1982.
12. Herman, T. S.; Hoppe, R. T.; Donaldson, S. S.; Cox, R. S.; Rosenberg, S. A.; Kaplan, H. S. Late relapses among patients treated for Hodgkin's disease. Ann. Intern. Med. 102:292-297; 1985.
13. Hoppe, R. T.; Coleman, C. N.; Cox, R. S.; Rosenberg, S.; Kaplan, H. S. The management of Stage I-II Hodgkin's disease with irradiation alone or combined modality therapy: The Stanford experience. Blood 59:455-465; 1982.
14. Hoppe, R. T.; Horning, S. J.; Rosenberg, S. A. The concept, evolution and preliminary results of the current Stanford clinical trials for Hodgkin's disease. Cancer Surv. 4:459-475; 1985.
15. Horning, S. J.; Hoppe, R. T.; Kaplan, H. S., et al. Female reproductive potential after treatment for Hodgkin's disease. N. Engl. J. Med. 304:1377; 1981.
16. Johnson, D. W.; Hoppe, R. T.; Cox, R. S.; Rosenberg, S. A.; Kaplan, H. S. Hodgkin's disease limited to intrathoracic sites. Cancer 52:8-13; 1983.
17. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
18. Leibenhaut, M. H.; Hoppe, R. T.; Efron, B., et al. Prognostic indicators at laparotomy findings in clinical Stage I-II supradiaphragmatic Hodgkin's disease. J. Clin. Oncol. 7:81-91; 1989.
19. Leslie, N. T.; Mauch, P. M.; Hellman, S. Stage IA to IIB supradiaphragmatic Hodgkin's disease, long-term survival and relapse frequency. Cancer 55:2072-2078; 1985.
20. Levitt, S. H.; Lee, C. K. K.; Aeppli, D.; Lindgren, B.; Peterson, B. A. The role of radiation therapy in Hodgkin disease: Experience and controversy. Cancer 70:693-703; 1992.
21. Levitt, S. H.; Lee, C. K. K.; Aeppli, D. M., et al. Radical treatment of Hodgkin's disease with radiation therapy: Results of a 15-year clinical trial (the 1985 Erskine Lecture). Radiology 162:623-630; 1987.
22. Longo, D. L.; Glatstein, E.; Duffey, P. L., et al. Radiation therapy versus combination chemotherapy in the treatment of early stage Hodgkin's disease: Seven-year results of a prospective randomized trial. J. Clin. Oncol. 906-917; 1991.
23. Mauch, P. M.; Canellos, G. P.; Shulman, L. N.; Silver, B.; Tarbell, N. J.; Come, S.; Rabin, M. S.; Coleman, C. N. Mantle irradiation alone for selected patients with laparotomy Staged IA to IIA Hodgkin's disease: Preliminary results of a prospective trial. J. Clin. Oncol. 13:947-952; 1995.
24. Mendenhall, N. P.; Cantor, A. B.; Barre', D. M.; Lynch, J. W., Jr.; Million, R. R. The role of prognostic factors in treatment selection for early-stage Hodgkin's disease. Am. J. Clin. Oncol. 17:189-195; 1994.
25. Noordijk, E. M.; Carde, P.; Mandard, A. M.; Mellink, W. A. M.; Monconduit, M.; Eghbali, H.; Tirelli, J.; Thomas, J.; Somers, R.; Dupouy, N.; Henry-Amar, M. Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early stage Hodgkin's disease. Ann. Oncol. 5:S107-S112; 1994.
26. Rodriguez, M. A.; Fuller, L. M.; Zimmerman, S. O.; Allen, P. K.; Brown, B. W.; Munsell, M. F.; Hagemeister, F. B.; McLaughlin, P.; Velasquez, W. S.; Swan, P., Jr.; Cabanillas, F. F. Hodgkin's disease: Study of treatment of intensities and incidents of second malignancies. Ann. Oncol. 4:125-131; 1993.
27. Tubiana, M.; Henry-Amar, M.; Hayat, M.; Burgers, M.; Qasim, M.; Somers, R.; Sizoo, W.; Van der Schueren, E. The EORTC treatment of early stages of Hodgkin's disease: The role of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 10:197-210; 1984.
28. Tubiana, M.; Henry-Amar, M.; Carde, P.; Burgers, J. M. V.; Hayat, M.; Van der Schueren, E.; Noordijk, E. M.; Tanguy, A.; Meerwaldt, J. H.; Thomas, J.; De Pauw, B.; Monconduit, M.; Cosset, J. M.; Somers, R. Toward comprehensive management tailored to prognostic factors of patients with clinical Stages I and II in Hodgkin's disease: The EORTC Lymphoma Group controlled clinical trials 1964-1987. Blood 73:47-56; 1989.
29. Tucker, M. A.; Coleman, C. N.; Cox, R. S., et al. Risk of second cancers after treatment for Hodgkin's disease. N. Engl. J. Med. 318:76-81; 1988.
30. Vijayakumar, S.; Myrianthopoulos, L. C. An updated dose response analysis in Hodgkin's disease, Radiother. Oncol. 24:1-13; 1992.